Literature DB >> 12297588

Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy.

Eduardo E Benarroch1, Ann M Schmeichel, Joseph E Parisi.   

Abstract

The authors immunocytochemically identified mesopontine cholinergic and rostral raphe serotonergic neurons in brains obtained at autopsy from four patients with multiple system atrophy (MSA) and four matched controls. There was a severe depletion of cholinergic neurons in the pedunculopontine (20 +/- 2 vs 81 +/- 10 cells/section, p< 0.001) and laterodorsal tegmental nucleus (18 +/- 3 vs 47 +/- 4 cells/section, p < 0.001) in MSA. Whereas there was also depletion of locus ceruleus neurons, there was a striking preservation of rostral raphe neurons in MSA.

Entities:  

Mesh：

Year:  2002        PMID： 12297588     DOI： 10.1212/wnl.59.6.944

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  22 in total

Review 1.  Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis.

Authors:  Jose-Alberto Palma; Clara Fernandez-Cordon; Elizabeth A Coon; Phillip A Low; Mitchell G Miglis; Safwan Jaradeh; Arijit K Bhaumik; Praveen Dayalu; Elena Urrestarazu; Jorge Iriarte; Italo Biaggioni; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2015-03-05       Impact factor: 4.435

2.  Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.

Authors:  Phillip A Low; David Robertson; Sid Gilman; Horacio Kaufmann; Wolfgang Singer; Italo Biaggioni; Roy Freeman; Susan Perlman; Robert A Hauser; William Cheshire; Stephanie Lessig; Steven Vernino; Jay Mandrekar; William D Dupont; Thomas Chelimsky; Wendy R Galpern
Journal:  Lancet Neurol       Date:  2014-02-05       Impact factor: 44.182

Review 3.  Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group.

Authors:  Iva Stankovic; Florian Krismer; Aleksandar Jesic; Angelo Antonini; Thomas Benke; Richard G Brown; David J Burn; Janice L Holton; Horacio Kaufmann; Vladimir S Kostic; Helen Ling; Wassilios G Meissner; Werner Poewe; Marija Semnic; Klaus Seppi; Atsushi Takeda; Daniel Weintraub; Gregor K Wenning
Journal:  Mov Disord       Date:  2014-04-18       Impact factor: 10.338

Review 4.  Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease.

Authors:  Maria Teresa Pellecchia; Rosario Pivonello; Annamaria Colao; Paolo Barone
Journal:  Clin Med Res       Date:  2006-12

Review 5.  Brainstem in multiple system atrophy: clinicopathological correlations.

Authors:  Eduardo E Benarroch
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

Review 6.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

7.  Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.

Authors:  Sylvia Stemberger; Werner Poewe; Gregor K Wenning; Nadia Stefanova
Journal:  Exp Neurol       Date:  2010-05-21       Impact factor: 5.330

8.  Loss of A5 noradrenergic neurons in multiple system atrophy.

Authors:  Eduardo E Benarroch; Ann M Schmeichel; Phillip A Low; Paola Sandroni; Joseph E Parisi
Journal:  Acta Neuropathol       Date:  2008-02-23       Impact factor: 17.088

9.  Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.

Authors:  Axel Lipp; Paola Sandroni; J Eric Ahlskog; Robert D Fealey; Kurt Kimpinski; Valeria Iodice; Tonette L Gehrking; Stephen D Weigand; David M Sletten; Jade A Gehrking; Kim K Nickander; Wolfgang Singer; Demetrius M Maraganore; Sid Gilman; Gregor K Wenning; Clifford W Shults; Phillip A Low
Journal:  Arch Neurol       Date:  2009-06

Review 10.  Modelling progressive autonomic failure in MSA: where are we now?

Authors:  Sylvia Stemberger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2011-01-08       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.